Efficacy and safety ofdigoxin alone and in combination with low-dosediltiazem orbetaxolol to control ventricular rate in chronic atrial fibrillation
- 1 January 1995
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 75 (1), 88-90
- https://doi.org/10.1016/s0002-9149(99)80538-4
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Optimal heart rate control for patients with chronic atrial fibrillation: Are pharmacologic choices truly changing?American Heart Journal, 1992
- Usefulness of labetalol in chronic atrial fibrillationThe American Journal of Cardiology, 1990
- Ventricular control and exercise performance in chronic atrial fibrillation: Effects of diltiazem verapamilJournal of the American College of Cardiology, 1990
- Comparative effects of nadolol-digoxin combination therapy and digoxin monotherapy for chronic atrial fibrillationThe American Journal of Cardiology, 1987
- Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation.BMJ, 1985
- Verapamil improves exercise capacity in chronic atrial fibrillation: Double-blind crossover studyAmerican Heart Journal, 1983
- Verapamil and digoxin: Their respective effects on atrial fibrillation and their interactionThe American Journal of Cardiology, 1982
- Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: Beneficial effect of an added beta adrenergic blocking agentThe American Journal of Cardiology, 1979
- Inefficacy of “therapeutic” serum levels of digoxin in controlling the ventricular rate in atrial fibrillationThe American Journal of Cardiology, 1975
- Hemodynamic Predictors of Myocardial Oxygen Consumption During Static and Dynamic ExerciseCirculation, 1974